6Vesa K Virtsnen, Heikki HT Saha, Kaj WE. Groundstroem,et al. Calcium infusion and left ventricular diastolic function in patients with chronic renal failure[ J]. Nephrol Dial Tran,1999,13(2) :384 - 388.
7Hans R,Brunner. Experimental and clinical evidence that angiontensin Ⅱ is an independent risk factor for cardiovascullar disease[ J] .Am J Cardiology,2001,87(8):3- 9.
8Watanabe K, Aizawa Y, Shibata A,et al.Depression of heart funcyion after angiotensin Ⅱ infusion in patients on chronic hemodialysis[ J] .Clin Exp Dial Apheresis, 1981,5(4) :249-259.
9Sadoshima J, Izumo S. Molecular characterization angiotensin Ⅱ- induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype[J]. Circ Res, 1993(3) :412 - 423.
10Kerstin Amann, Peter Gassmann, Moriz Buzello, et al. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rat[J] .Kidney Int,2000,58(1):153-161.
6Iseki K, Tozawa M, Yoshi S, et al. Serum C-reactive and risk of Death in chronic hemodialysis patients [J] . Nephrol Dial Transplant, 1999, 14: 1956-1960.
7Arora P, Kauza AT, Obrador GT, et al. Hosipital utilization among chronic dialysis patients [ J ] . J Am Soc Nephrol, 2000, 11 : 740-746.
8Lysaght MJ. Maintenance dialysis population dunamice: current tends and longterm implication [J]. J Am Soc Nephrol, 2002, 12: S37-S40.
